Assessing rates of hypoglycemia as an end point in clinical trials
Diabetes Care
.
2015 Oct;38(10):e160-1.
doi: 10.2337/dc15-0808.
Epub 2015 Aug 17.
Authors
Douglas B Muchmore
1
,
Lutz Heinemann
2
,
William Tamborlane
3
,
Xionghua W Wu
4
,
Alexander Fleming
5
Affiliations
1
Kinexum, La Jolla, CA lajollaendollc@gmail.com.
2
Science & Co, Düsseldorf, Germany.
3
Yale School of Medicine, New Haven, CT.
4
Halozyme Therapeutics, San Diego, CA.
5
Kinexum, Harpers Ferry, WV.
PMID:
26283738
DOI:
10.2337/dc15-0808
No abstract available
Publication types
Letter
MeSH terms
Blood Glucose / metabolism
Blood Glucose Self-Monitoring
Clinical Trials as Topic*
Endpoint Determination*
Humans
Hypoglycemia / blood
Hypoglycemia / diagnosis*
Substances
Blood Glucose